The latest announcement is out from Ondine Biomedical, Inc. ( (GB:OBI) ).
Ondine Biomedical Inc. has joined the CAN Health Network, a national initiative aimed at accelerating the adoption of Canadian healthcare technology. This membership will provide Ondine with strategic support and connections to advance its Steriwave technology, which has shown significant reductions in surgical infections and cost savings in hospitals. The collaboration is expected to enhance Ondine’s market reach and contribute to improved health outcomes in Canada and potentially globally.
More about Ondine Biomedical, Inc.
Ondine Biomedical Inc. is a Canadian life sciences company specializing in light-activated antimicrobial therapies, known as photodisinfection, for preventing and treating infections, including those caused by multidrug-resistant organisms. The company has a range of investigational products in development and its nasal photodisinfection system, Steriwave, is approved in several countries and undergoing clinical trials in the US.
Average Trading Volume: 158,124
Technical Sentiment Signal: Sell
Current Market Cap: £39.89M
Learn more about OBI stock on TipRanks’ Stock Analysis page.